Health
Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology
CASTRES, France and CAMBRIDGE, England, Sept. 25, 2023 /PRNewswire/ -- Pierre Fabre Laboratories and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets. ...
2023-09-25 15:00
1516
Power Up with Energizer's Re-Energize 100% Fitfest this October
Open For Individuals Aged 13 And Above, The 3-Day Fitness-Packed Fest Is Now Open For Registration And Give Your Car The Finish It Deserves At Armor All Carwash Section KUALA LUMPUR, Malaysia, Sept. 25, 2023 /PRNewswire/ -- Energizer Malaysia announcesRe-Energize 100% Fitfest, a power-packed fit...
2023-09-25 11:48
2103
'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia
* Bridging the gap on lack of discussion amongst Asian women on their health concerns this World Contraception Day (WCD) SINGAPORE, Sept. 25, 2023 /PRNewswire/ -- Bayer Pharmaceuticals Division inAsia/Pacific announced today in conjunction with World Contraception Day, the inception of its 'Ba...
2023-09-25 09:56
2324
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate®) First-in-Class Candidate for the Treatment of Intermediate Dry AMD
SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychi...
2023-09-25 09:00
2490
ASTRAZENECA AND INSTITUT KANSER NEGARA PARTNER TO INTRODUCE AI TECHNOLOGY FOR LUNG SCREENING
The partnership paves the way for the adoption of AI technology in chest x-ray for early lung screening at government health facilities KUALA LUMPUR, Malaysia, Sept. 22, 2023 /PRNewswire/ -- In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaborat...
2023-09-25 09:00
2933
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
SHANGHAI, Sept. 25, 2023 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of HANSIZHUANG (serplulimab injection), an innovative anti-PD-1 monoclonal antibody independently developed by the company, in combination with drugs...
2023-09-25 07:41
2012
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility
SALT LAKE CITY, Sept. 22, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 100,000-square-foot expansion of their operations inBrooklyn Park, Minnesota, bringing the facility ...
2023-09-22 22:03
2125
The UNICEF Charity Run 2023 Hosted Runners Calling Ceremony
Registration Closing Soon and Calling on Everyone to Run for Every Child! HONG KONG, Sept. 22, 2023 /PRNewswire/ -- UNICEF Charity Run 2023, the largest charity road race event inHong Kong, will be held on the 5th of November this year at Hong Kong Disneyland Resort andSunny Bay. A Runners Calli...
2023-09-22 13:42
2025
BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.
Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI MILAN, Sept. 21, 2023 /PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a leading innovator in artificial intelligence (AI)-powered image acquisition, have entered into a...
2023-09-21 22:00
2962
New Wacom Signature Displays expand digital signature capture options for healthcare, financial services and transaction management
HONG KONG, Sept. 21, 2023 /PRNewswire/ -- Wacom announces its new Signature Displays the 13 touch (DTH134) and 12 (DTC121), a new eDocument solution enabling digital transformation initiatives. With an extremely simple, plug-and-play single cable connection, the Wacom Signature Displays enable a...
2023-09-21 18:45
4071
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
- The Phase I "PERFORM" study will evaluate the safety and tolerability, pharmacology, immunogenicity, and preliminary efficacy of ATG-031 in patients with advanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL). - ATG-031,discovered and developed in-house by Antengene,is the world's firs...
2023-09-21 18:05
2115
Latest Sports & Fitness Innovation: Holistic Training Syllabus by MAVERICKS Life Co.
CRANS-MONTANA, Switzerland, Sept. 21, 2023 /PRNewswire/ -- Sports science & wellbeing education company, MAVERICKS Life Co., announces the release of its new Holistic Training Syllabus, rooted in evolutionary biology and epigenetics theory. It's a brand new innovation in the sports and fitness se...
2023-09-21 15:00
2487
Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023
SEOUL, South Korea, Sept. 21, 2023 /PRNewswire/ -- Yuyu Healthcare will
participate in the Vitafoods Asia 2023 event inBangkok, Thailand with the goal
of entering the global market.
2023-09-21 14:06
2371
ADM Joins GAR and Tzu Chi Indonesia to Accelerate Progress in Indonesia's Rural Economies
* ADM partners with Golden Agri-Resources (GAR) and Tzu Chi Indonesia to expand the reach of rural development initiatives. * The programme will enhance access to childcare and promote sustainable rural entrepreneurship inIndonesia's Riau province. JAKARTA, Indonesia, Sept. 21, 2023 /PRNewswi...
2023-09-21 12:10
2391
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB
HANGZHOU, China, Sept. 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, today announced the successful completion of Series C2 financing. This round of financing was jointly participated by the Shaox...
2023-09-21 08:00
2670
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets
SHANGHAI, Sept. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today it has entered into a collaboration and license...
2023-09-21 07:05
2310
Diana Bracco: "Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses"
MILAN, Sept. 21, 2023 /PRNewswire/ -- Unlocking the AI Revolution - A Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence is the title describing the theme of the 2023 edition of Bracco Innovation Day. This event took place at the Human ...
2023-09-21 01:47
2305
European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation
* Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more than 147,000 breast cancer patients inEurope die annually from the disease² * ORSERDU is the first treatment specifically for patients with ER+, HE...
2023-09-20 23:27
2309
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies
News Summary: * New Zeta Star™ instrument for nanoparticle analysis from Wyatt Technology™ portfolio combines three light scattering techniques into a single device – cutting measurement time by up to 10x[i] over other methods. * Measures biologic drug products at extremely low sample volume...
2023-09-20 20:00
2124
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmologic, neurological and psychiat...
2023-09-20 09:00
2452
Week's Top Stories
Most Reposted
2024 Malaysia E-Commerce Product Selection Expo Attracts International Delegations
[Picked up by 308 media titles]
2024-12-02 12:06
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 285 media titles]
2024-11-29 20:33
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
8430
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5185